Skip to main content
Log in

IVF/ICSI in a woman with active acromegaly: Successful outcome following treatment with pegvisomant

  • Case Report
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

A 29 year old woman with difficult to control acromegaly and a pituitary macroadenoma responded to pegvisomant therapy and subsequently conceived with her first cycle of in-vitro fertilization and intra-cytoplasmic sperm injection. Pregnancy was complicated by gestational diabetes, pituitary gland enlargement and deteriorating visual fields. Conservative management with elective cesarean section was performed at 32 weeks gestation. A healthy boy was delivered who remains developmentally normal at 1 year. This complex case required intricate care by a multi-disciplinary team and is likely to represent the first in many cases of assisted conception on pegvisomant therapy for active acromegaly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Molitch ME. Pregnancy and the hyperprolactinemic woman. New England J Medi 1985;312(21):1364–70.

    Article  CAS  Google Scholar 

  2. Sauder SE, Frager M, Case GD, Kelch RP, Marshall JC. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine. J Clin Endocrinol Metab 1984;59(5):941–8.

    Article  PubMed  CAS  Google Scholar 

  3. Wislawski J, Hartwig W, Kasperlik-Zaluska A, Ostrowski K. Treatment of acromegaly by the surgical approach through the sphenoid bone. Clinical results. Polish J Neurol Neurosurg 1982;16(4):281–6.

    CAS  Google Scholar 

  4. Kupersmith MJ, Rosenberg C, Kleinberg D. Visual loss in pregnant women with pituitary adenomas. Ann Inter Med 1994;121(7):473–7.

    CAS  Google Scholar 

  5. Herman-Bonert V, Seliverstov M, Melmed S. Pregnancy in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab 1998;83(3):727–31.

    Article  PubMed  CAS  Google Scholar 

  6. Berelowitz M, HowGo E. Non-insulin diabetes mellitus secondary to other endocrine disorders. In: LeRoith D, Taylor SI, Olefsky JM eds. Diabetes mellitus. A fundamental and clinical text. New York: Lippincott-Raven 1996;496–502.

  7. Parks JS. The ontogeny of growth hormone sensitivity. Hormone Res 2001;55(Suppl 2):27–31.

    Article  PubMed  CAS  Google Scholar 

  8. Pacifici GM, Nottoli R. Placental transfer of drugs administered to the mother. Clin Pharmacokinet 1995;28(3):235–69.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr Isaac Manyonda for helpful discussion and advice in the preparation of this report.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Asjid Qureshi.

Additional information

This case report describes a successful pregnancy, managed by a functional multi-disciplinary team, following assisted conception in a subject with active acromegaly treated with pegvisomant.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qureshi, A., Kalu, E., Ramanathan, G. et al. IVF/ICSI in a woman with active acromegaly: Successful outcome following treatment with pegvisomant. J Assist Reprod Genet 23, 439–442 (2006). https://doi.org/10.1007/s10815-006-9077-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-006-9077-6

Keywords

Navigation